Free Delivery for orders above R750 in South Africa.
FILLMED P-Bright Serum
R2 110.00
Targeted Serum to eliminate and improve ark spots and pigmentation, uneven skin tone and lack of radiance.
Type Of Skin: Pigmentation / Textured Skin
About Fillmed
Dedicated to aesthetic medicine since 1978.Laboratories FILLMED, experts in anti-ageing, develop aesthetic and cosmetic treatment solutions using hyaluronic acid and high-performance active ingredients. FILLMED enters in the era of Positive Pro-Ageing to address the concerns of young and more mature patients.
Complement Cosmetic Procedures:
Developed by a French laboratory leading in cosmetic medicine and skin quality, Skin Perfusion is an innovative cosmeceutical range especially designed to maintain and enhance the results of cosmetic procedures.
High-performance Solutions:
Formulated with high-grade ingredients in optimal concentrations, Skin Perfusion products are based on the Mix & Match principle to achieve the best visible results on skin appearance and to best fit the needs of each skin through tailor-made solutions.
FILLMED P-Bright Serum
Benefits:
- Visibly acts on cutaneous uniformity
- Fades dark spots
- Brightens the complexion
- Mild enzymatic exfoliator with a unifying and radiance-enhancing effect
How To Use:
Application Area Face
Frequency of Use Twice a day
Moment of Use Morning and evening
Apply on a cleansed skin before moisturiser.
Key Ingredients:
- Vitamin C
- Phytic acid
- Arabino-xyloses ϐ1-4
- Papain-Carbomer
Ingredients:
Aqua (Water Eau), Isopentyldoil, Glycereth-26, Pentylene Glycol, 2-0-Rhyl, Ascorbic Acid, Phytic Acid, Cyclopentasiloxane, Phenoxyethanol, Cyclohexasiloxane, Sodium Hydroxide, Hydrolyzed Wheat Flour, Betaine, Xanthan Gum, Acrylates/C10-30, Alkyl, Acrylate Crosspolymer, Sodium Hyaluronate, Papain, 1-2-Hexanediol, Caprylyl Glycol, Carbomer, Algin, Citric Acid
Precautions/Contraindications:
- Allergy to any of the ingredients.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.